anti-MAP3K14 (MAP3K14) 抗体产品概述

Full name:: anti-Mitogen-Activated Protein Kinase Kinase Kinase 14 抗体 (MAP3K14)

在www.antibodies-online.cn可供133 Mitogen-Activated Protein Kinase Kinase Kinase 14 (MAP3K14) 抗体的26不同的供货商。再加上，我们可以发MAP3K14 蛋白 (9)和数多这个蛋白质的别的产品。总共156 MAP3K14产品已列进来了。

别名:: aly, F23F1.4, F23F1_4, FTDCR1B, HS, HSNIK, mitogen-activated protein kinase kinase kinase 14, Nik

列出全部抗体	基因	基因ID	UniProt
	MAP3K14	9020	Q99558
	MAP3K14	360640
	MAP3K14	53859	Q9WUL6
显示所有的来源显示所有的同义词

最受欢迎的抗anti-MAP3K14 (MAP3K14) 抗体

选择您的来源和应用

抗Human MAP3K14 抗体:

抗Rat (Rattus) MAP3K14 抗体:

抗Mouse (Murine) MAP3K14 抗体:

所有可销售的anti-MAP3K14 抗体

您会转到已过滤好的搜索

显示和anti-MAP3K14 抗体相应的途径

引用最多的anti-MAP3K14 抗体

Human Polyclonal MAP3K14 Primary Antibody for WB - ABIN392539 : Bouzakri, Zierath: MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor-alpha-induced insulin resistance. in The Journal of biological chemistry 2007 (PubMed)
Show all 4 Pubmed References

更多抗MAP3K14的相互作用对抗体

Human Mitogen-Activated Protein Kinase Kinase Kinase 14 (MAP3K14) interaction partners

Data show that breast cancer stem cells (BCSCs) expressed higher levels of NF-kappaB (显示 NFKB1 抗体)-inducing kinase (NIK).
These findings highlight the importance of NIK in tumor pathogenesis and invite new therapeutic strategies that attenuate mitochondrial dysfunction through inhibition of NIK and Drp1 (显示 CRMP1 抗体).
results suggest that changes in the relative concentrations of RelB (显示 RELB 抗体), NIK:IKK1, and p100 (显示 CUX1 抗体) during noncanonical signaling modulate this transitional complex and are critical for maintaining the fine balance between the processing and protection of p100 (显示 CUX1 抗体).
report a detailed state-of-the-art mass spectrometry-based protein-protein interaction network including the noncanonical NF-kappaB (显示 NFKB1 抗体) signaling nodes TRAF2 (显示 TRAF2 抗体), TRAF3 (显示 TRAF3 抗体), IKKalpha (显示 CHUK 抗体), NIK, and NF-kappaB2/p100 (显示 CUX1 抗体); also provide a differential interactome of NIK mutants that cause immunodeficiency
OLFM1 (显示 OLFM1 抗体) is a negative regulator of non-canonical NF-kappaB (显示 NFKB1 抗体) signalling by interacting with and inhibiting NIK. Thus, OLFM1 (显示 OLFM1 抗体) may serve as a valuable biomarker and therapeutic target for colorectal cancer (CRC (显示 CALR 抗体)) patients.
The expression of OTUD7B (显示 OTUD7B 抗体) and NIK were negatively correlated in non-small cell lung cancer tumor samples. the higher expression of NIK was related to more lymph node metastasis and later TNM (显示 ODZ1 抗体) stage. high OTUD7B (显示 OTUD7B 抗体)/low NIK index can predict an good prognosis.
NIK expression was significantly increased in the tumor tissue of patients with breast carcinoma, which may be an important factor that affects the prognosis of these patients.
This study identified two novel independent loci (MAP3K14 and CARD9 (显示 CARD9 抗体)) strongly associated with joint damage in Mexican Americans and European Americans and a few shared loci showing suggestive evidence for association.
The forced expression of NDRG2 (显示 NDRG2 抗体) in ATL cells down-regulates not only the canonical pathway by inhibiting AKT (显示 AKT1 抗体) signaling but also the non-canonical pathway by inducing NF-kappaB (显示 NFKB1 抗体)-inducing kinase (NIK) dephosphorylation via the recruitment of PP2A (显示 PPP2R4 抗体)
NIK(+) endothelial cells may play an important role in the persistence of synovitis

Mouse (Murine) Mitogen-Activated Protein Kinase Kinase Kinase 14 (MAP3K14) interaction partners

Nik (显示 MAP4K4 抗体)(-/-) mice could be useful as a spontaneous model of specific features of Eosinophilic esophagitis.
global or thymus-specific ablation of the NIK (显示 MAP4K4 抗体) gene results in fatal autoimmune liver disease in mice.
These findings highlight the importance of NIK (显示 MAP4K4 抗体) in tumor pathogenesis and invite new therapeutic strategies that attenuate mitochondrial dysfunction through inhibition of NIK (显示 MAP4K4 抗体) and Drp1 (显示 CRMP1 抗体).
constitutive activation of NIK (显示 MAP4K4 抗体) in the hematopoietic system leads to bone marrow (BM) failure and postnatal lethality.
results suggest that changes in the relative concentrations of RelB (显示 RELB 抗体), NIK:IKK1, and p100 (显示 PATL2 抗体) during noncanonical signaling modulate this transitional complex and are critical for maintaining the fine balance between the processing and protection of p100 (显示 PATL2 抗体).
NIK (显示 MAP4K4 抗体) pathways in both hepatocytes and immune cells act in concert to promote liver steatosis and glucose production in the setting of obesity.
this study demonstrates that although NIK (显示 MAP4K4 抗体) is dispensable for thymocyte development, it has a cell-intrinsic role in regulating the homeostasis and function of peripheral T cells
Using a novel conditional mutant of NIK (显示 MAP4K4 抗体), the authors could show in vivo that NIK (显示 MAP4K4 抗体) signaling in thymic epithelial cells is essential for the thymic hardwiring of gammadelta T cell cytokine production.
NIK (显示 MAP4K4 抗体) not only contributes to lymphoid organogenesis, inflammation and cell survival but also to TNFR1 (显示 TNFRSF1A 抗体)/RIP1 (显示 RALBP1 抗体)-dependent cell death independently of the alternative NF-kappaB (显示 NFKB1 抗体) pathway.
This study demonstrated that NFkappaB-inducing kinase inhibits NFkappaB activity specifically in neurons of the CNS.

MAP3K14 抗原简介

Antigen Summary

This gene encodes mitogen-activated protein kinase kinase kinase 14, which is a serine/threonine protein-kinase. This kinase binds to TRAF2 and stimulates NF-kappaB activity. It shares sequence similarity with several other MAPKK kinases. It participates in an NF-kappaB-inducing signalling cascade common to receptors of the tumour-necrosis/nerve-growth factor (TNF/NGF) family and to the interleukin-1 type-I receptor.

Alternative names and synonyms associated with MAP3K14

mitogen-activated protein kinase kinase kinase 14 (MAP3K14) 抗体
mitogen-activated protein kinase kinase kinase 14 (Map3k14) 抗体
mitogen-activated protein kinase kinase kinase 14 (MAPKKK14) 抗体

aly 抗体
F23F1.4 抗体
F23F1_4 抗体
FTDCR1B 抗体
HS 抗体
HSNIK 抗体
mitogen-activated protein kinase kinase kinase 14 抗体
Nik 抗体

Protein level used designations for MAP3K14

NF-kappa-beta-inducing kinase , serine/threonine protein-kinase , serine/threonine-protein kinase NIK , NF kappa B-inducing kinase , Nfkb inducing kinase , alymphoplasia , protein kinase , mitogen-activated protein kinase kinase kinase 14

GENE ID	SPECIES
9020	Homo sapiens
360640	Rattus norvegicus
817555	Arabidopsis thaliana
53859	Mus musculus
100719582	Cavia porcellus
100351032	Oryctolagus cuniculus
508367	Bos taurus
490926	Canis lupus familiaris
100050140	Equus caballus
100520402	Sus scrofa

anti-MAP3K14 (MAP3K14) 抗体精选生产商

您还需要查找其他产品吗？

电话:	+1 877 302 8632
传真:	+1 888 205 9894 (Toll-free)
电子邮件:	orders@antibodies-online.cn

Show all anti-Mitogen-Activated Protein Kinase Kinase Kinase 14 (MAP3K14) 抗体 with Pubmed References

Human Mitogen-Activated Protein Kinase Kinase Kinase 14 (MAP3K14) interaction partners

Mouse (Murine) Mitogen-Activated Protein Kinase Kinase Kinase 14 (MAP3K14) interaction partners

Antigen Summary

Alternative names and synonyms associated with MAP3K14

Protein level used designations for MAP3K14